|
CONVERTIBLE DEBENTURES (Tables)
|
3 Months Ended |
|
Jan. 31, 2014
|
| CONVERTIBLE DEBENTURES (Tables) [Line Items] |
|
| Convertible Debt [Table Text Block] |
|
Face value of Convertible Debenture due January 2015
|
|
|
|
$
|
1,765,000
|
|
Fair value of embedded conversion feature
|
$
|
1,180,000
|
|
|
|
|
Relative fair value of Convertible Debenture Warrant
|
|
214,819
|
|
|
|
|
Discount
|
$
|
1,394,819
|
|
|
(1,394,819)
|
|
Proceeds attributable to the Convertible Debenture due January 2015
|
|
|
|
$
|
370,181
|
|
Face value of Convertible Debenture due November 2016
|
|
|
|
$
|
3,500,000
|
|
Fair value of embedded conversion feature
|
$
|
1,570,000
|
|
|
|
|
Relative fair value of Convertible Debenture Warrant
|
|
515,936
|
|
|
|
|
Discount
|
$
|
2,085,936
|
|
|
(2,085,936)
|
|
Proceeds attributable to the Convertible Debenture due November 2016
|
|
|
|
$
|
1,414,064
|
|
| Schedule of Debt Issuance Cost [Table Text Block] |
|
Attributable to:
|
|
Accounting Treatment
|
|
Amount
|
|
|
|
|
|
|
|
|
The embedded conversion feature (derivative)
|
|
Expensed as incurred
|
|
$
|
55, 999
|
|
The 8% Convertible Debenture Warrant
|
|
Charged to additional paid-in capital
|
|
|
10,194
|
|
|
|
|
|
|
|
|
The 8% Convertible Debenture
|
|
Recorded as deferred issuance costs and amortized under the interest method over the term of the 8% Convertible Debenture
|
|
|
17,567
|
|
Total
|
|
|
|
$
|
83,760
|
|
Attributable to:
|
|
Accounting Treatment
|
|
Amount
|
|
|
|
|
|
|
|
|
The embedded conversion feature (derivative)
|
|
Expensed as incurred
|
|
$
|
8,593
|
|
The 8% Convertible Debenture Warrant
|
|
Charged to additional paid-in capital
|
|
|
2,824
|
|
|
|
|
|
|
|
|
The 8% Convertible Debenture
|
|
Recorded as deferred issuance costs and amortized under the interest method over the term of the 8% Convertible Debenture
|
|
|
7,739
|
|
Total
|
|
|
|
$
|
19,156
|
|
|
Embeded Derivatives Conversion Features [Member]
|
|
| CONVERTIBLE DEBENTURES (Tables) [Line Items] |
|
| Schedule of Assumptions for Fair Value as of Balance Sheet Date of Assets or Liabilities that relate to Transferor's Continuing Involvement [Table Text Block] |
|
|
As of
January 25,
2013
|
|
|
|
|
Stock price on valuation date
|
$
|
0.21
|
|
Conversion price
|
$
|
0.15
|
|
Stock premium for liquidity
|
|
57%
|
|
Term (years)
|
|
2.00
|
|
Expected volatility
|
|
110%
|
|
Weighted average risk-free interest rate
|
|
0.3%
|
|
Trials
|
|
100,000
|
|
Aggregate fair value
|
$
|
1,180,000
|
|
|
|
|
|
|
As of
January 31,
2014
|
|
|
|
|
Stock price used for valuation
|
$
|
0.303
|
|
Conversion price
|
|
0.15
|
|
Discount for marketability
|
|
38.3%
|
|
Term (years)
|
|
1.00
|
|
Expected volatility
|
|
87.7%
|
|
Weighted average risk-free interest rate
|
|
0.1%
|
|
Trials
|
|
100,000
|
|
Aggregate fair value
|
$
|
1,020,000
|
|
|
|
|
|
|
As of
November 11,
2013
|
|
|
|
|
Stock price on valuation date
|
$
|
0.20
|
|
Conversion price
|
$
|
0.189
|
|
Discount for lack of marketability
|
|
35.5%
|
|
Term (years)
|
|
3.00
|
|
Expected volatility
|
|
102.8%
|
|
Weighted average risk-free interest rate
|
|
0.62%
|
|
Trials
|
|
100,000
|
|
Aggregate fair value
|
$
|
1,570,000
|
|
|
|
|
|
|
January 31,
2014
|
|
|
|
|
Stock price used for valuation
|
$
|
0.303
|
|
Conversion price
|
|
0.189
|
|
Discount for lack of marketability
|
|
38.3%
|
|
Term (years)
|
|
2.8
|
|
Expected volatility
|
|
105%
|
|
Weighted average risk-free interest rate
|
|
0.6%
|
|
Trials
|
|
100,000
|
|
Aggregate fair value
|
$
|
2,410,000
|
|
|
|
|
|
|
Convertible Debenture Warrant [Member]
|
|
| CONVERTIBLE DEBENTURES (Tables) [Line Items] |
|
| Schedule of Assumptions for Fair Value as of Balance Sheet Date of Assets or Liabilities that relate to Transferor's Continuing Involvement [Table Text Block] |
|
|
As of
January 25,
2013
|
|
|
|
|
Stock price on valuation date
|
$
|
0.21
|
|
Exercise price
|
$
|
0.30
|
|
Stock premium for liquidity
|
|
38%
|
|
Term (years)
|
|
3.00
|
|
Warrant exercise trigger price
|
|
41%
|
|
Expected volatility
|
|
95%
|
|
Weighted average risk-free interest rate
|
|
0.4%
|
|
Number of warrants
|
|
5,882,745
|
|
Aggregate fair value
|
$
|
370,000
|
|
|
As of
November 11,
2013
|
|
|
|
|
Stock price on valuation date
|
$
|
0.20
|
|
Exercise price
|
$
|
0.378
|
|
Discount for lack of marketability
|
|
22%
|
|
Term (years)
|
|
3.00
|
|
|
|
|
|
Expected volatility
|
|
102.8%
|
|
Weighted average risk-free interest rate
|
|
0.6%
|
|
Number of warrants
|
|
9,249,472
|
|
Aggregate fair value
|
$
|
740,000
|
|
|
|
|
|